Physician

Bahaeddin A. El Khatib, M.D.

According to 2025 Medicare claims, Bahaeddin Khatib, M.D. (NPI: 1417481946) practices ophthalmology in the Canton-Massillon, OH market, with the plurality of this provider's patient population coming from Stark, OH. This provider's primary affiliated billing organization is VITREO-RETINAL CONSULTANTS, INC. (NPI: 1750347662; TIN: 341390523) and primary practice location at 44718-3619.

Khatib's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 919 traditional Medicare patients, billed 24,687 HCPCS/CPT codes, and received $2,441,008 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 834 prescription claims across 264 beneficiaries totaling $24,011 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 41 records totaling $1,338. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $471 and ending at $24,011. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.2M$2.4M2021 Medicare payment: $5,225 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $7,469 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $174,422 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,441,008 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
20213961$5,225
202260118$7,469
20232131,324$174,422
202491924,687$2,441,008

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$19K$38K2017 Drug cost: $471 (USD; Tot_Drug_Cst)2018 Drug cost: $9,068 (USD; Tot_Drug_Cst)2019 Drug cost: $37,540 (USD; Tot_Drug_Cst)2020 Drug cost: $19,073 (USD; Tot_Drug_Cst)2021 Drug cost: $17,747 (USD; Tot_Drug_Cst)2022 Drug cost: $22,497 (USD; Tot_Drug_Cst)2023 Drug cost: $11,501 (USD; Tot_Drug_Cst)2024 Drug cost: $24,011 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R14$471
20183069$9,068
2019106251$37,540
202082180$19,073
202191259$17,747
2022124331$22,497
202396231$11,501
2024264834$24,011

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg2071,444$659
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more5001,434$87
67028Injection of drug into eye4801,533$87
92014Established patient complete exam of visual system378512$81
92134Imaging of retina8432,117$28

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate2558,069$9,758
Ketorolac TromethamineKetorolac Tromethamine1103,156$4,788
OfloxacinOfloxacin1403,544$1,730
Brimonidine TartrateBrimonidine Tartrate231,175$1,339
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha1251,978$1,307

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.41$1,338Alimera Sciences, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Bahaeddin A. El Khatib, M.D.?

Tedicare shows public-source Medicare data for Bahaeddin A. El Khatib, M.D. (NPI 1417481946), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bahaeddin A. El Khatib, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Bahaeddin A. El Khatib, M.D.?

Bahaeddin A. El Khatib, M.D. is linked to VITREO-RETINAL CONSULTANTS, INC. (billing NPI 1750347662) in the available physician profile data.

Does Bahaeddin A. El Khatib, M.D. have Open Payments data?

Bahaeddin A. El Khatib, M.D. has 41 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.